Kevin Imrie

6.2k total citations · 1 hit paper
90 papers, 2.7k citations indexed

About

Kevin Imrie is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Kevin Imrie has authored 90 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pathology and Forensic Medicine, 44 papers in Oncology and 33 papers in Genetics. Recurrent topics in Kevin Imrie's work include Lymphoma Diagnosis and Treatment (53 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Viral-associated cancers and disorders (22 papers). Kevin Imrie is often cited by papers focused on Lymphoma Diagnosis and Treatment (53 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Viral-associated cancers and disorders (22 papers). Kevin Imrie collaborates with scholars based in Canada, Poland and United Kingdom. Kevin Imrie's co-authors include Matthew C. Cheung, Michael Crump, Rena Buckstein, Andrew R. Belch, Ralph M. Meyer, Armand Keating, Neil L. Berinstein, Fritz Offner, Philippe Solal‐Céligny and Adam E. Haynes and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Kevin Imrie

88 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Systematic Review of the Effects of Resident Duty Hour Restrictions in Surgery

2014 338 citations Najma Ahmed, Kevin Imrie et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Imrie Canada	27	1.3k	1.2k	745	552	349	90	2.7k
D Milligan United Kingdom	26	1.4k 1.0×	1.1k 1.0×	1.0k 1.4×	1.1k 2.1×	371 1.1×	62	3.0k
Simon Crouch United Kingdom	20	1.1k 0.8×	741 0.6×	656 0.9×	322 0.6×	238 0.7×	49	2.0k
Nils Feltelius Sweden	32	1.0k 0.7×	439 0.4×	736 1.0×	801 1.5×	148 0.4×	79	4.1k
Auke Beishuizen Netherlands	29	718 0.5×	503 0.4×	347 0.5×	699 1.3×	208 0.6×	110	2.5k
Roberto Passera Italy	35	551 0.4×	1.6k 1.4×	232 0.3×	508 0.9×	185 0.5×	153	3.9k
James S. Miser United States	32	718 0.5×	780 0.7×	221 0.3×	278 0.5×	830 2.4×	83	4.4k
Craig A. Hurwitz United States	31	384 0.3×	847 0.7×	310 0.4×	1.1k 1.9×	442 1.3×	64	3.6k
Gerald S. Gilchrist United States	32	751 0.6×	478 0.4×	221 0.3×	605 1.1×	343 1.0×	87	3.1k
Reinhard Stauder Austria	36	534 0.4×	976 0.8×	1.4k 1.8×	2.7k 4.9×	113 0.3×	122	4.9k
Smith Giri United States	29	274 0.2×	991 0.9×	488 0.7×	1.2k 2.2×	80 0.2×	262	3.2k

Countries citing papers authored by Kevin Imrie

Since Specialization

Citations

This map shows the geographic impact of Kevin Imrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Imrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Imrie more than expected).

Fields of papers citing papers by Kevin Imrie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Imrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Imrie. The network helps show where Kevin Imrie may publish in the future.

Co-authorship network of co-authors of Kevin Imrie

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Imrie. A scholar is included among the top collaborators of Kevin Imrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Imrie. Kevin Imrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morgan, Sarah, Rosemarie Tremblay‐LeMay, Joan E. Lipa, et al.. (2021). Breast implant-associated EBV-positive diffuse large B-cell lymphoma: Two case reports and literature review. Pathology - Research and Practice. 226. 153589–153589. 16 indexed citations

Brydges, Ryan, Lynfa Stroud, Brian M. Wong, et al.. (2017). Core Competencies or a Competent Core? A Scoping Review and Realist Synthesis of Invasive Bedside Procedural Skills Training in Internal Medicine. Academic Medicine. 92(11). 1632–1643. 26 indexed citations

Cheung, Matthew C., Annette E. Hay, Michael Crump, et al.. (2015). Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12. JNCI Journal of the National Cancer Institute. 107(7). 20 indexed citations

Baldassarre, Fulvia, et al.. (2014). Bortezomib in Multiple Myeloma: Systematic Review and Clinical Considerations. Current Oncology. 21(4). 573–603. 97 indexed citations

Cheung, Matthew C., Eugenia Piliotis, David Spaner, et al.. (2014). Survival of patients with transformed lymphoma in the rituximab era. Annals of Hematology. 93(6). 1007–1014. 27 indexed citations

Imrie, Kevin, Jason R. Frank, Najma Ahmed, Lisa Gorman, & Kenneth D. Harris. (2013). A new era for resident duty hours in surgery calls for greater emphasis on resident wellness. Canadian Journal of Surgery. 56(5). 295–296. 4 indexed citations

Kouroukis, C. Tom, Fulvia Baldassarre, Adam E. Haynes, et al.. (2013). Bortezomib in Multiple Myeloma: A Practice Guideline. Clinical Oncology. 26(2). 110–119. 18 indexed citations

Imrie, Kevin, et al.. (2011). High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma. Leukemia & lymphoma. 52(10). 1882–1890. 13 indexed citations

Hicks, Lisa K., Rena Buckstein, Joy Mangel, et al.. (2008). Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma. Bone Marrow Transplantation. 43(9). 701–708. 56 indexed citations

10.

Shehata, Nadine, et al.. (2008). The use of erythropoiesis-stimulating agents in patients with non-myeloid hematological malignancies: a systematic review. Annals of Hematology. 87(12). 961–973. 15 indexed citations

11.

Hicks, Lisa K., Adam E. Haynes, Donna Reece, et al.. (2008). A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma. Cancer Treatment Reviews. 34(5). 442–452. 52 indexed citations

12.

Cheung, Matthew C., Adam E. Haynes, Ralph M. Meyer, Adrienne Stevens, & Kevin Imrie. (2007). Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario. Cancer Treatment Reviews. 33(2). 161–176. 47 indexed citations

13.

Cheung, Matthew C., Kevin Imrie, Heather A. Leitch, et al.. (2007). Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphoma. Annals of Hematology. 86(9). 631–638. 3 indexed citations

14.

Mangel, Joy, Heather A. Leitch, Joseph M. Connors, et al.. (2004). Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis. Annals of Oncology. 15(2). 283–290. 76 indexed citations

15.

Imrie, Kevin, David C. Linch, & Myron S. Czuczman. (2002). Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkinʼs lymphoma. Anti-Cancer Drugs. 13. S19–S24. 6 indexed citations

16.

Mangel, Joy, Rena Buckstein, Kevin Imrie, et al.. (2002). Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Seminars in Oncology. 29(1). 56–69. 46 indexed citations

17.

Schimmer, Aaron D., et al.. (2001). Male sexual function after autologous blood or marrow transplantation. Biology of Blood and Marrow Transplantation. 7(5). 279–283. 23 indexed citations

18.

Schimmer, Aaron D., Kevin Imrie, A. Keith Stewart, et al.. (1998). Ovarian function after autologous bone marrow transplantation.. Journal of Clinical Oncology. 16(7). 2359–2363. 67 indexed citations

19.

Hsu, Jane Lu, H. Miles Prince, & Kevin Imrie. (1996). Prolonged Ciprofloxacin Administration Does Not Accelerate Neutrophil Recovery after Autologous Bone Marrow Transplantation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(4). 652–655. 1 indexed citations

20.

Minden, Mark D., Kevin Imrie, & Armand Keating. (1996). Acute leukemia in adults. Current Opinion in Hematology. 3(4). 259–265. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact